Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Down, Turner and Klinefelter syndromes
Paediatrics and child health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending
Overview
Recognise Down, Turner and Klinefelter syndromes across childhood, confirm the chromosome diagnosis, anticipate age-specific health needs, support development and identity, and coordinate endocrine, cardiac, fertility and transition care.
Down, Turner and Klinefelter syndromes are chromosome conditions with wide variation between individuals. Diagnosis may follow prenatal screening, a newborn phenotype, growth or developmental assessment, delayed puberty, infertility or an incidental chromosome result. Confirm the cytogenetic finding rather than relying on appearance. Record whether the result is full, mosaic or structural, whether parental chromosomes are indicated and which service owns counselling. The diagnosis supplies a risk framework, not a complete description of the child.
For Down syndrome, immediate priorities are ordinary neonatal stabilisation plus targeted assessment for common associated disease. DSMIG advises a full blood count and peripheral blood film for every newborn by day three to detect transient abnormal myelopoiesis; blasts above the relevant threshold or clinical TAM features need urgent specialist haematology-oncology discussion and GATA1 testing as directed. Symptomatic babies or those with abnormal cardiovascular signs or ECG need urgent or accelerated paediatric cardiac assessment. Even when examination and ECG are normal, cardiology assessment and echocardiography should occur by about six weeks because important congenital heart disease can be clinically silent.
Feeding effectiveness, weight, bilirubin, hearing, red reflex, thyroid screening and gastrointestinal patency are reviewed during the same neonatal period. Bilious vomiting or delayed meconium needs surgical assessment. Families should leave with Down-syndrome-specific growth charts, written follow-up and named contacts. Later surveillance covers hearing, vision, thyroid, growth, sleep-disordered breathing, coeliac disease, dental health and development, while any new symptom is assessed rather than attributed automatically to the chromosome diagnosis.
Development in Down syndrome is uneven rather than uniformly limited. Hearing loss, visual impairment, sleep-disordered breathing, thyroid disease, coeliac disease, constipation, pain and safeguarding concerns can worsen function and behaviour. Investigate regression, new seizures, gait change or loss of continence rather than calling it part of the syndrome. Support speech and language, motor skills, school inclusion, communication aids and family priorities. Capacity is decision-specific; involve the young person and never assume incapacity from diagnosis.
Turner syndrome care is led by growth, cardiovascular and gonadal consequences but remains multisystem. Echocardiography and often cardiac MRI define bicuspid valve, coarctation and aortic dimensions. Blood pressure should be measured correctly at each review, including limb comparison when clinically relevant. Renal anatomy, hearing, thyroid, liver, glucose, lipids, coeliac risk, bone health and psychosocial wellbeing are reviewed over time. Growth hormone can improve adult height when specialist criteria are met; oestrogen is introduced gradually at a developmentally appropriate age and later combined with progestogen after uterine oestrogen exposure or bleeding according to the endocrine plan.
Klinefelter syndrome is often underdiagnosed in childhood because features are subtle. Language, executive function, coordination and school progress may need support, while height often accelerates and testes remain small. Pubertal testosterone production may be insufficient despite some spontaneous virilisation. Measure gonadotrophins and testosterone in context rather than diagnosing from habitus alone. Specialist discussion covers testosterone replacement when clinically indicated, gynaecomastia, bone and metabolic health, thrombosis risk, sexual function and fertility assessment. Testicular sperm extraction may be possible for selected adults, but no outcome should be promised.
Adolescence requires staged disclosure and private consultation. Explain the chromosome finding in language the young person can use, revisit questions as understanding develops and invite them to choose who is involved. Discuss menstruation, sexual health, contraception, relationships and fertility without assumptions. Turner pregnancy can carry major cardiovascular risk and needs specialist preconception assessment; oocyte preservation or donation options depend on ovarian reserve, heart status, age and commissioning. Klinefelter reproductive planning needs andrology expertise. Adoption and donor conception are possibilities but should never be framed as compulsory consolation.
Transition should specify adult ownership. Down syndrome commonly needs primary-care annual health review and condition-specific referral. Turner syndrome requires lifelong cardiology and endocrine follow-up even after height treatment ends, with gynaecology, fertility and hearing input. Klinefelter follow-up may involve endocrinology, primary care, bone, metabolic and reproductive services. Provide an emergency cardiovascular summary where appropriate, a current medicine and monitoring plan, and a record of communication or reasonable adjustments.
Key points
Down syndrome is usually trisomy 21; confirm the chromosome result and distinguish free trisomy, translocation and mosaicism because parental testing and recurrence advice differ.
Every newborn with Down syndrome needs a full blood count and peripheral blood film by day three to screen for transient abnormal myelopoiesis, plus a defined cardiac pathway even when the initial examination appears reassuring.
Turner syndrome should be considered in unexplained short stature, neonatal lymphoedema, left-sided cardiac lesions, delayed puberty, primary amenorrhoea or ovarian insufficiency.
A confirmed Turner diagnosis needs expert cardiac imaging and blood-pressure surveillance, renal assessment, hearing care, thyroid and metabolic monitoring, growth review and planned pubertal induction.
Klinefelter syndrome may present with language or learning needs, tall stature, small firm testes, incomplete virilisation, gynaecomastia, infertility or hypergonadotrophic hypogonadism.
Chromosome results do not predict personality, ability, gender identity, sexuality, fertility or severity; use person-centred language and assess the individual rather than a stereotype.
Discuss puberty and fertility progressively in private as well as with family, offering preservation or reproductive advice early enough for meaningful choice.
Aetiology
01
Trisomy twenty-one
Down syndrome usually results from meiotic nondisjunction causing an additional chromosome 21; translocation and mosaic forms are less common and alter family counselling.
02
X chromosome monosomy
Turner syndrome reflects complete or partial loss or structural alteration of one X chromosome in a phenotypic female, often with tissue mosaicism.
03
Additional X chromosome
Klinefelter syndrome commonly has a 47,XXY complement in a phenotypic male; mosaic and higher aneuploidies contribute to variable presentation.
Pathophysiology
1
Gene dosage imbalance
Extra chromosome 21 material changes expression across developmental pathways, producing recognisable neurodevelopmental, cardiac, gastrointestinal, endocrine and haematological susceptibilities.
2
SHOX haploinsufficiency
Loss of one functional SHOX copy contributes to short stature and characteristic skeletal proportions in Turner syndrome.
3
Gonadal dysgenesis
Accelerated follicular loss in Turner syndrome commonly causes ovarian insufficiency, while seminiferous-tubule failure in Klinefelter syndrome produces small firm testes and impaired spermatogenesis.
4
Sex steroid deficiency
Insufficient oestrogen or testosterone affects pubertal progression, bone acquisition, body composition, metabolic health, sexuality and psychosocial wellbeing without defining the person's identity.
Clinical features and red flags
Down syndrome pattern
Neonatal hypotonia, characteristic facial features, single palmar crease and congenital cardiac or gastrointestinal findings can prompt confirmatory chromosome testing.
Turner growth pattern
Unexplained short stature, poor growth velocity, neonatal hand or foot swelling, neck webbing or left-sided cardiac disease are important clues.
Turner pubertal pattern
Absent breast development, primary amenorrhoea or raised gonadotrophins with low oestrogen can reveal ovarian insufficiency in an undiagnosed adolescent.
Klinefelter pubertal pattern
Tall stature, persistently small firm testes, limited virilisation, gynaecomastia or raised gonadotrophins may indicate an additional X chromosome.
Learning presentation
Language, attention or executive difficulty can occur in all three conditions but is variable and requires individual educational assessment.
Red flags requiring action
A newborn with suspected Down syndrome who is cyanosed, tachypnoeic, poorly feeding or shocked needs urgent assessment for congenital heart disease and other neonatal illness.
Bilious vomiting, marked abdominal distension or failure to pass meconium in an infant with Down syndrome requires emergency surgical evaluation for obstruction.
New gait change, limb weakness, neck pain, sphincter disturbance or upper motor-neurone signs in Down syndrome raises possible cervical cord compression and needs urgent imaging advice.
Investigations
01Chromosome analysisFirst step
Why
Confirm chromosome number, mosaicism or a structural rearrangement underlying the phenotype.
Interpretation and limitations
The exact karyotype guides diagnosis and whether parental studies or more detailed copy-number testing are appropriate.
02Cardiac assessment
Why
Detect congenital lesions, ventricular effects, aortopathy and hypertension relevant to syndrome.
Interpretation and limitations
In Down syndrome, abnormal signs or ECG accelerate specialist review, but normal findings still require cardiology and echocardiography by about six weeks; Turner follow-up is individualised by anatomy and indexed aortic dimensions.
03Neonatal full blood count and film
Why
Screen every newborn with Down syndrome for transient abnormal myelopoiesis by day three.
Interpretation and limitations
An experienced neonatal film review should report blasts; more than ten percent blasts or compatible clinical illness prompts urgent specialist discussion and GATA1 analysis.
04Thyroid and metabolic profile
Why
Identify treatable endocrine, liver, glucose and lipid abnormalities over time.
Interpretation and limitations
Interpret against age and symptoms; normal early results do not remove the need for scheduled surveillance.
Differential diagnosis
01
Other trisomy or copy-number disorder
Congenital anomalies, hypotonia and developmental difference can reflect another chromosome imbalance, so phenotype alone should not substitute for confirmation.
02
Noonan syndrome
Short stature, neck webbing, lymphoedema and congenital heart disease can resemble Turner syndrome but occur with a different genomic mechanism and in any sex.
03
Constitutional pubertal delay
Delayed puberty with otherwise typical growth and family late maturation can mimic hypogonadism, but gonadotrophins, examination and trajectory distinguish it.
04
Other primary gonadal failure
Gonadal injury, autoimmune disease, developmental disorder and treatment toxicity can cause hypergonadotrophic hypogonadism without X chromosome aneuploidy.
05
Isolated learning or language disorder
School difficulty is common and nonspecific; chromosome testing is guided by the whole developmental, growth, examination and family phenotype.
Management
01ConfirmDefine the chromosome diagnosisFirst stepPrenatal, newborn, growth, developmental or pubertal features suggest aneuploidy.+
1Stabilise urgent clinical problems and document the complete phenotype without delaying necessary care.
2Request the eligible chromosome test and obtain genetics or paediatric interpretation of the exact result.
3Explain mosaic or structural findings and arrange parental studies when they change recurrence counselling.
02SurveyCreate an organ-specific calendarDown, Turner or Klinefelter syndrome has been confirmed.+
1For a Down syndrome newborn, obtain FBC and film by day three and complete urgent or six-week cardiac review according to signs and ECG.
2Complete remaining baseline growth, sensory, developmental, endocrine and syndrome-specific assessments with named owners.
Complications
01
Cardiovascular disease
Septal and atrioventricular defects occur in Down syndrome, while bicuspid aortic valve, coarctation, hypertension and aortopathy are central Turner risks.
02
Endocrine and metabolic disease
Thyroid dysfunction, obesity and diabetes risks vary across the syndromes; ovarian or testicular failure adds bone and reproductive consequences.
03
Hearing and visual impairment
Conductive or sensorineural hearing loss, refractive error and ocular disease can silently worsen communication, learning and social participation.
04
Fertility limitation
Most people with classic Turner or Klinefelter syndrome have reduced fertility, although mosaicism and specialist reproductive techniques make individual assessment essential.
05
Psychosocial inequity
Diagnostic overshadowing, inaccessible information, bullying and assumptions about competence or sexuality can cause avoidable harm beyond the biological condition.
Monitoring and follow-up
For Down syndrome, confirm the day-three FBC and film and the neonatal cardiac pathway were completed before following the age-based hearing, vision, thyroid, growth, sleep, coeliac, dental and developmental schedule.
For Turner syndrome, record blood pressure and cardiovascular status throughout life, with imaging intervals set by specialist anatomy and aortic measurements.
Track growth and pubertal response alongside IGF-1 or safety monitoring for sex steroids when specialist hormone treatment is used.
For Klinefelter syndrome, review puberty, testosterone status, bone health, metabolic risk, learning, mental wellbeing and fertility preferences over time.
At every stage check communication needs, school participation, bullying, sexuality, consent and the young person's understanding of their diagnosis.
Transfer original karyotype and cardiac reports at transition rather than relying solely on a syndrome name in the problem list.
Special situations
Mosaicism changes probability
A mosaic chromosome result can modify expression and fertility but cannot predict an individual's future from cell percentage alone.
Symptoms still need diagnosis
A known chromosome condition increases selected risks but should never become a shortcut that replaces examination and appropriate investigation.
Puberty is more than hormones
Replacement care includes body understanding, consent, relationships, sexual wellbeing, fertility and a pace acceptable to the young person.
Cardiac risk outlives paediatrics
People with Turner syndrome need explicit adult cardiovascular ownership even when childhood scans were reassuring and growth treatment is complete.
Ability cannot be read from karyotype
Educational, communication and decision support must be based on assessment of the person rather than chromosome stereotypes.
Common pitfalls
01
Diagnosing a chromosome syndrome from appearance without laboratory confirmation.
02
Using the syndrome label to explain every new symptom or behavioural change.
03
Stopping Turner cardiac follow-up after growth hormone or paediatric discharge.
04
Starting full adult-dose replacement with sex steroids during pubertal induction without gradual titration.
05
Discussing fertility only with parents and excluding the competent young person.
06
Assuming mosaicism guarantees mild disease or preserved fertility.
Practice
Two practice questions
Your practice draft is saved in this browser.
Question 1 of 2
0 correct
Paediatrics and child healthOriginal SBA
Turner cardiovascular continuity
A 16-year-old with Turner syndrome completed growth treatment and feels well. Childhood imaging showed a bicuspid aortic valve. Which transition plan is most appropriate?
Sources and review status7 sources · checked 27 Aug 2026 · clinical review pending+
Sources
Sources and review status
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.
NHS Down syndrome overviewDiagnosis, associated health needs, development and support for people with Down syndrome.
DSMIG neonatal Down syndrome guidanceUK specialist neonatal surveillance route, including congenital heart disease and transient abnormal myelopoiesis screening.
DSMIG haematological conditionsDay-three full blood count and film, blast interpretation, GATA1 testing and urgent referral for neonatal TAM.
BSPED clinical guidelinesUK paediatric endocrine resources relevant to growth and pubertal induction.
Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem ·
Coordinate school support, reasonable adjustments, transition and adult follow-up; avoid allowing a familiar syndrome label to obscure a new treatable symptom.
A child with Turner syndrome and chest or back pain, collapse, severe hypertension or acute breathlessness requires emergency assessment for aortic disease.
Headache, visual symptoms or severe hypertension in a child receiving growth hormone or sex steroids requires prompt endocrine review and assessment for treatment complications.
Acute testicular pain in any boy or young man, including someone with Klinefelter syndrome, follows the emergency torsion pathway rather than being attributed to the chromosome diagnosis.
05
Hearing and ophthalmic assessment
Why
Find sensory impairment that can affect communication, development and safety.
Interpretation and limitations
Formal age-appropriate testing is needed because behaviour or school difficulty may be the presenting sign.
06Gonadotrophins and sex steroids
Why
Assess ovarian or testicular function when puberty is absent, incomplete or symptomatic.
Interpretation and limitations
Raised LH or FSH with low sex steroids supports primary gonadal insufficiency, interpreted with pubertal stage and treatment.
07Fertility assessment
Why
Clarify reproductive potential when the young person wishes and timing is clinically useful.
Interpretation and limitations
Ovarian reserve or semen findings inform specialist options but cannot guarantee spontaneous or assisted conception.
3
Investigate new symptoms on their merits while using the syndrome to prioritise dangerous associations.
03PubertySupport physiological developmentPuberty is delayed, incomplete or associated with gonadal insufficiency.+
1Assess pubertal stage, growth, gonadotrophins, sex steroids, bone health and the young person's goals.
2Introduce specialist replacement with sex steroids gradually when indicated and monitor development and adverse effects.
3Discuss fertility, sexuality, contraception, identity and privacy through repeated age-appropriate conversations.
04TransitionTransfer lifelong risk ownershipThe young person approaches adult services or leaves paediatric follow-up.+
1Create a concise diagnosis, anatomy, treatment, surveillance and communication-adjustment summary.
2Confirm named adult cardiology, endocrine, primary-care and reproductive contacts according to need.
3Give the young person direct access to results, emergency advice and supported decision-making resources.
Key medicines and prescribing safety3 treatments · regimens, roles and cautions+
Promotes linear growth in eligible girls with Turner syndrome before epiphyseal closure.
Somatropin in Turner syndrome
A paediatric endocrine specialist selects a daily subcutaneous weight- or surface-area-based regimen under the current product licence and growth protocol, titrating against growth response and IGF-1 rather than using a fixed adult dose.
Monitor growth velocity, IGF-1, glucose, thyroid function, headache, visual symptoms, hip or knee pain and scoliosis; pause and investigate possible intracranial hypertension or slipped epiphysis promptly.
Induces puberty and supports uterine, bone, cardiovascular and psychosocial health in ovarian insufficiency.
Oestradiol for pubertal induction
Begin with a very low specialist transdermal or oral oestradiol dose and increase stepwise over roughly two to three years toward adult replacement; add progestogen after sufficient oestrogen exposure or bleeding according to the individual plan.
Avoid immediate adult dosing, review migraine and thrombotic context, monitor blood pressure, growth, pubertal progress and bleeding, and coordinate fertility and cardiac considerations in Turner syndrome.
Supports virilisation, muscle, bone, energy, sexual function and wellbeing when endogenous testosterone is insufficient.
Testosterone replacement
When Klinefelter-associated androgen deficiency is established, paediatric or adult endocrinology starts an age-appropriate formulation at a low induction dose or standard replacement dose after puberty and titrates to clinical response and measured testosterone.
Monitor mood, acne, haematocrit, blood pressure, lipids, liver context and sleep-disordered breathing; discuss fertility before treatment where sperm retrieval timing could be relevant.